SCHEMBL4708679

SCHEMBL4708679

Clc1cccc(-c2nc(CCN3CCCCn4c(-c5ccncc5)nnc43)no2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.47
CYP3A4 P08684 1/20 0.40
BCHE P06276 1/20 0.37
NPC1 O15118 5/20 0.37
RAB9A P51151 4/20 0.37
MAPT P10636 3/20 0.37
TP53 P04637 3/20 0.37
MITF O75030 1/20 0.37
PKM P14618 1/20 0.37
TSHR P16473 1/20 0.37
GRM5 P41594 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOB P27338 4/20 0.36
MAOA P21397 1/20 0.36
ADORA2A P29274 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4327916 0.91 KCNH2 (0.47) KCNH2CYP3A4BCHENPC1RAB9A
SCHEMBL1544442 0.89 KCNH2 (0.47) KCNH2CYP3A4BCHENPC1RAB9A
SCHEMBL5482293 0.80 P2RX7 (0.40) KCNH2NPC1RAB9AMAPTTP53
SCHEMBL5478892 0.79 MAPT (0.40) KCNH2NPC1RAB9AMAPTTP53
SCHEMBL4336808 0.79 MAPT (0.38) KCNH2NPC1RAB9AMAPTTP53
SCHEMBL4338428 0.78 MAPT (0.44) KCNH2NPC1RAB9AMAPTTP53
SCHEMBL1544852 0.78 KCNH2 (0.45) KCNH2CYP3A4BCHENPC1RAB9A
SCHEMBL4331877 0.77 KCNH2 (0.57) KCNH2BCHENPC1RAB9AMAPT
SCHEMBL4329337 0.77 NPC1 (0.44) KCNH2BCHENPC1RAB9AMAPT
SCHEMBL4329314 0.76 KCNH2 (0.48) KCNH2CYP3A4BCHENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716152-B1 FUSED HETROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS ASTRAZENECA AB (SE) 2008-07-30 EP disclosed